Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

被引：0
|
作者：
Kim, Jin-Hyo [1 ]
Park, Sung-Soo [1 ]
Yoon, Jae-Ho [1 ]
Lee, Sung-Eun [1 ]
Kim, Hee-Je [1 ]
Min, Chang-Ki [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hematol Hosp, Coll Med, Dept Hematol, 222 Banpodaero, Seoul 06591, South Korea
来源：
BLOOD RESEARCH | 2022年 / 57卷 / 01期
关键词：
CD38;
D O I：
10.5045/br.2022.2021183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 80
页数：5
相关论文
共 50 条
  • [31] Role of Daratumumab in Combination With Standard Therapies in Patients With Relapsed and Refractory Multiple Myeloma
    Bapatla, Anusha
    Kaul, Arunima
    Dhalla, Paramvijay Singh
    Armenta-Quiroga, Ana S.
    Khalid, Raheela
    Garcia, Jian
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [32] Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia
    Cook, Gordon
    Corso, Alessandro
    Streetly, Matthew
    Mendeleeva, Larisa P.
    Ptushkin, Vadim V.
    Chan, Edmond
    Ukropec, Jon
    Iraqi, Wafae
    Al-Akabawi, Assem
    Pei, Huiling
    Gaudig, Maren
    Petrucci, Maria Teresa
    Alegre, Adrian
    Mateos, Maria-Victoria
    ONCOLOGY AND THERAPY, 2021, 9 (01) : 139 - 151
  • [33] TIMING OF FORCED EXPIRATORY VOLUME IN ONE SECOND
    SMITH, AA
    GAENSLER, EA
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1975, 112 (06): : 882 - 885
  • [34] Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia
    Gordon Cook
    Alessandro Corso
    Matthew Streetly
    Larisa P. Mendeleeva
    Vadim V. Ptushkin
    Edmond Chan
    Jon Ukropec
    Wafae Iraqi
    Assem Al-Akabawi
    Huiling Pei
    Maren Gaudig
    Maria Teresa Petrucci
    Adrian Alegre
    Maria-Victoria Mateos
    Oncology and Therapy, 2021, 9 : 139 - 151
  • [35] Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma
    Dimopoulos, Meletios
    Bringhen, Sara
    Anttila, Pekka
    Capra, Marcelo
    Cavo, Michele
    Cole, Craig
    Gasparetto, Cristina
    Hungria, Vania
    Jenner, Matthew
    Vorobyev, Vladimir
    Ruiz, Eduardo Yanez
    Yin, Jian Y.
    Saleem, Rao
    Hellet, Maeva
    Mace, Sandrine
    Paiva, Bruno
    Vij, Ravi
    BLOOD, 2021, 137 (09) : 1154 - 1165
  • [36] Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma
    Hoylman, Emily
    Brown, Anna
    Perissinotti, Anthony J.
    Marini, Bernard L.
    Pianko, Matthew
    Ye, Jing Christine
    Campagnaro, Erica
    Nachar, Victoria R.
    LEUKEMIA & LYMPHOMA, 2020, 61 (03) : 691 - 698
  • [37] Daratumumab and its use in the treatment of relapsed and/or refractory multiple myeloma
    Chehab, Sarah
    Panjic, Elyse Hall
    Gleason, Charise
    Lonial, Sagar
    Nooka, Ajay K.
    FUTURE ONCOLOGY, 2018, 14 (30) : 3111 - 3121
  • [38] Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
    Chari, Ajai
    Suvannasankha, Attaya
    Fay, Joseph W.
    Arnulf, Bertrand
    Kaufman, Jonathan L.
    Ifthikharuddin, Jainulabdeen J.
    Weiss, Brendan M.
    Krishnan, Amrita
    Lentzsch, Suzanne
    Comenzo, Raymond
    Wang, Jianping
    Nottage, Kerri
    Chiu, Christopher
    Khokhar, Nushmia Z.
    Ahmadi, Tahamtan
    Lonial, Sagar
    BLOOD, 2017, 130 (08) : 974 - 981
  • [39] SAFETY OF RAPID DARATUMUMAB INFUSION IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Attardi, E.
    Antonioli, E.
    Staderini, M.
    Messeri, M.
    Buzzichelli, A.
    Nencini, V.
    Fani, A.
    Bosi, A.
    HAEMATOLOGICA, 2019, 104 : 65 - 66
  • [40] Safety of rapid daratumumab infusion in relapsed and refractory multiple myeloma
    Antonioli, Elisabetta
    Attardi, Enrico
    Staderini, Michela
    Nozzoli, Chiara
    Buzzichelli, Alessandra
    Messeri, Maria
    Bosi, Alberto
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E141 - E141
12345